معرفی
Steven Darby is a Senior Lecturer at the University of Sunderland, where he has taught since 2015 in the Pharmacy, Biopharmaceutical Sciences, and Biomedical Sciences programs. He holds a BSc (Hons) in Applied Chemistry and Biochemistry, an MSc in Applied Microbiology and Biotechnology, and a PhD in Surgical Oncology from Newcastle University focusing on prostate cancer metastasis mechanisms. His academic career includes research positions at the Forensic Science Service (DNA fingerprinting), University of Sheffield (DNA sequencing), and Northern Institute for Cancer Research (cancer drug development).
Darby's research centers on molecular oncology with three primary themes: 1) Investigating aberrant intracellular signaling in cancer progression using molecular biology techniques, 2) Developing novel anti-cancer compounds targeting key regulatory pathways, and 3) Bioinformatics analysis of gene signatures involved in cancer development. His work emphasizes prostate cancer mechanisms, growth factor signaling, and post-translational protein modifications.
Publication analysis reveals consistent focus on prostate cancer pathophysiology spanning 2001-2019, with recent work exploring nanomedicine (2019) and ubiquitination pathways (2016). Key recurring themes include FGF signaling, androgen receptor regulation, and identification of therapeutic targets. His collaborative network includes Newcastle Medical School and Sunderland's School of Pharmacy.
Professional affiliations include:
- Member of the Royal Society of Chemistry (MRSC)
- Chartered Chemist (CChem)
- Fellow of the Higher Education Academy (FHEA)
- Accredited Biosafety Practitioner
- Professional Membership of British Association for Cancer Research
- Professional Membership of the American Association for Cancer Research
